Tech13 hours ago
FDA clears drug for rare and deadly GI cancer developed by Canadian firm Zymeworks
Co-founder of Zymeworks calls approval “the dream that many said was not possible.”
The United States Food and Drug Administration (FDA) has approved the use...
